MA13.05 TA0953/HM06, a Novel RET-specific Inhibitor Effective in Extracranial and CNS Disease Models of NSCLC with RETfusions.

Autor: Odintsov, I., Lui, A.J.W., Delasos, L., Khodos, I., Chang, Q., Mattar, M.S., Vojnic, M., Lu, Y.C., Kunte, S., Bonifacio, A., Giuliano, C., de Stanchina, E., Lovati, E., Ladanyi, M., Somwar, R.
Zdroj: Journal of Thoracic Oncology; 2022 Supplement, Vol. 17 Issue 9, pS90-S91, 2p
Databáze: Complementary Index